Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to tr... Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to treat a rare monogenic muscle disease. 詳細を表示
Avidity Biosciences Announces New Precision Cardiology Development Candidates to Treat Rare Genetic Cardiomyopathies and Provides First Look at Next-Generation Technology Innovations PR...
Avidity Biosciences Reports Third Quarter 2024 Financial Results and Recent Highlights PR Newswire SAN DIEGO, Nov. 7, 2024 Enrollment in global Phase 3 HARBOR™ study for del-desiran in DM1 is on...
Avidity Biosciences to Host Investor and Analyst Event Focused on Precision Cardiology Candidates and First Look at Next-Generation Technology Innovations on November 12, 2024 PR Newswire SAN...
Avidity Biosciences Pursues Potential Accelerated Approval Path with Initiation of Biomarker Cohort in FORTITUDE™ Trial for Delpacibart Braxlosiran (del-brax/AOC 1020) in People Living with...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -9.87 | -18.4658559401 | 53.45 | 54.24 | 39.5 | 1321694 | 44.40897378 | CS |
4 | -1.89 | -4.1565867605 | 45.47 | 56 | 39.5 | 1090952 | 46.10829476 | CS |
12 | -0.34 | -0.774134790528 | 43.92 | 56 | 39.3509 | 1256085 | 44.98121774 | CS |
26 | 14.58 | 50.275862069 | 29 | 56 | 25.03 | 1426710 | 42.08391564 | CS |
52 | 37.54 | 621.523178808 | 6.04 | 56 | 5.68 | 1382200 | 29.49966569 | CS |
156 | 15.7 | 56.31276901 | 27.88 | 56 | 4.825 | 998153 | 21.72465355 | CS |
260 | 24.93 | 133.672922252 | 18.65 | 56 | 4.825 | 757052 | 22.13593128 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約